Value and Evidence, Field Director

ImmunityBio, Inc.•El Segundo, CA

1d•Remote

About The Position

The Value and Evidence, Field Director will be a hybrid role integrating evidence generation/HEOR strategy with scientific and pharmacoeconomic communications for ImmunityBio, Inc. products within the United States (U.S.). This role will be responsible for engaging U.S.-based National and Regional managed care accounts, PBMs, Medicaid/Medicare, Integrated Delivery Networks (IDNs), and Federal institutions (DoD, VA) to support optimal patient access in non–muscle invasive bladder cancer (NMIBC), in support of the Market Access team. The Value and Evidence Field Director will align Health Economics and Outcomes Research (HEOR) strategy and evidence generation with payer needs to help educate formulary decision makers on the unmet medical needs in the disease states of interest to while reducing payer uncertainty. The goal is to strengthen the value proposition of ImmunityBio’s products and enable appropriate patient access to innovative medicines. This position combines field-based payer engagements with novel evidence generation, pharmacoeconomic modeling, and cross-functional project leadership responsibilities.

Requirements

Advanced degree (Ph.D., Pharm.D., M.D., MPH, or equivalent) in a relevant scientific or health‑related discipline required.
10+ years of progressive experience in the pharmaceutical, biotechnology, or healthcare‑consulting sectors with a demonstrated knowledge, skills, and capabilities in applications of health‑economics & outcomes research (HEOR), real‑world evidence (RWE) study design, data management, scientific writing and publications, health systems and managed care organizational operations, and project management required.
Experience and demonstrated expertise in solid tumors, preferably genitourinary oncology required.
Direct experience engaging in oncology-focused value discussions and formulary presentations with national and regional payers, PBMs, and Federal accounts required.
A professional record of developing and executing integrated evidence strategies that have supported successful product launches, market‑access approvals, and high‑impact alliance initiatives required.
Demonstrated understanding of the pharmaceutical industry, clinical development process, and ability to interpret complex clinical, scientific, and pharmacoeconomic data.
Strong understanding of oncology pathways, clinical guidelines (NCCN, AUA/SUO, EAU, etc.) and contemporary reimbursement and formulary management frameworks.
Proven executive presence and ability to lead and influence cross-functionally.
Recognition as a thought leader evidenced by peer‑reviewed publications, conference presentations, and active participation in professional societies.
Critical understanding of HTA processes (NICE, ICER), payer requirements, regulatory frameworks, and diverse health‑care systems.
Competence in designing and executing comparative-effectiveness and pharmacoeconomic modeling; proficiency with statistical methods, claims‑databases, EMR databases, and health‑economic modeling tools.
Advanced strategic‑planning ability to create multi-year payer‑engagement roadmaps that align evidence‑generation timelines, regulatory milestones, and commercial launch activities; includes payer segmentation, resource prioritization, and cross‑functional team coordination.
Ability to manage external vendors, define milestones, track deliverables, ensure compliance with timelines and budgets, and maintain comprehensive dashboards for leader updates.
Exceptional written and oral communication skills with ability to translate complex clinical and technical scientific data into succinct, persuasive, payer‑focused narratives for non-clinical stakeholders (e.g., formulary committees, health plan executives) via scientific briefings and targeted presentations.
Proven negotiation and relationship‑building capabilities to engage payer decision‑makers, influence formulary outcomes by establishing scientific credibility and understanding payer business drivers.
Interpersonal skills and influence to facilitate cross‑functional communication, drive decision‑making, accomplish work without formal authority, and ensure alignment with internal and external stakeholders.
Sound judgment, problem‑solving, and matrix management skills in selecting study design, methods, and analytical techniques for obtaining clinical and economic solutions.
Proficiency in MS Word, Excel, PowerPoint, Outlook, OneNote, Visio, Adobe, Veeva CRM, and project management platforms (e.g., Monday.com, Smartsheet).
Detail‑oriented with solid organization and time management skills.
Committed to maintaining corporate confidentiality at all times.

Nice To Haves

Experience collaborating with external data partners, academic institutions, and contract research organizations is highly desirable.
People management experience is a plus.

Responsibilities

Partner with the Vice President, Medical Affairs – Strategy to develop and execute medical market access strategies that establish the clinical rationale, economic value, and scientific positioning of ImmunityBio products.
Lead medical affairs and HEOR initiatives that support payer engagement and formulary placement by integrating clinical data, competitive intelligence, and payer insights.
Develop value-based frameworks and evidence-based arguments that communicate clinical and economic value to C-suite executives, Medical Directors, Pharmacy Directors, and formulary decision-makers.
Present integrated clinical, real-world evidence (RWE), and pharmacoeconomic data to payer stakeholders to inform coverage and reimbursement decisions.
Author and co-author clinical and pharmacoeconomic abstracts, posters, and presentations for scientific and payer-focused congresses.
Utilize FDAMA 114 (Section 3037) tools and communications appropriately across Commercial, PBM, Federal, and State Government accounts.
Ensure all payer-focused medical activities comply with company policy, applicable laws, and industry codes while maintaining scientific integrity and risk-management standards.
Partner with Medical Affairs, Market Access, Marketing, Clinical Development, Regulatory, Legal, and Advocacy teams to advance HEOR education and patient access to ImmunityBio treatments.
Provide real-time payer landscape intelligence to Medical Affairs and Commercial leadership to inform business strategy, early product development, and lifecycle optimization.
Contribute to the development and maintenance of Integrated Evidence Generation Plans for marketed and pipeline products.
Build and maintain relationships with national and regional payer stakeholders and key opinion leaders (KOLs).
Manage project budgets and timelines to deliver high-quality HEOR data and real-world evidence.
Lead or contribute to strategic initiatives and special projects that advance Medical Affairs and organizational objectives.
Maintain expertise in healthcare economics, payer analytics, and therapeutic innovation; translate emerging trends into actionable strategies that enhance competitive advantage.
Perform ad-hoc and cross-functional duties and/or projects, as assigned, to support business needs and provide developmental opportunities.

Benefits

Medical, Dental and Vision Plan Options
Health and Financial Wellness Programs
Employer Assistance Program (EAP)
Company Paid and Voluntary Life/AD&D, Short-Term and Long-Term Disability
Healthcare and Dependent Care Flexible Spending Accounts
401(k) Retirement Plan with Company Match
529 Education Savings Program
Voluntary Legal Services, Identity Theft Protection, Pet Insurance and Employee Discounts, Rewards and Perks
Paid Time Off (PTO) includes: 11 Holidays
Exempt Employees are eligible for Unlimited PTO
Non-Exempt Employees are eligible for 10 Vacation Days, 56 Hours of Health Pay, 2 Personal Days and 1 Cultural Day